Health
Tiny antibody component shows high potency in SARS-CoV-2 animal models – News-Medical.Net
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19.
Reviewed by Emily Henderson, B.Sc.Sep 14 2020
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19. This antibody component, which is 10 times smaller than a full-sized antibody, has been used to construct a drug–known as Ab8–for potential use as a therapeutic and prophylactic against SARS-CoV-2.
The researchers report today in the journal…
-
Noosa News23 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business23 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News23 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News11 hours agoNew self-serve style chip shop, Chip ‘n’ Mix, in Noosa becomes an instant obsession